CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,111,623 | +73.8% | 4,845,717 | +5.3% | 0.00% | +100.0% |
| Q2 2023 | $82,900,758 | +30.5% | 4,600,486 | +16.3% | 0.00% | 0.0% |
| Q1 2023 | $63,539,110 | -11.4% | 3,956,358 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $71,690,049 | -2.7% | 3,917,489 | +4.4% | 0.00% | -33.3% |
| Q3 2022 | $73,688,000 | +4.3% | 3,752,022 | -1.0% | 0.00% | +50.0% |
| Q2 2022 | $70,675,000 | -2.3% | 3,789,483 | +14.9% | 0.00% | 0.0% |
| Q1 2022 | $72,365,000 | -22.3% | 3,296,780 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $93,077,000 | +69.0% | 3,276,170 | +25.2% | 0.00% | 0.0% |
| Q3 2021 | $55,084,000 | +12.7% | 2,616,839 | +0.9% | 0.00% | +100.0% |
| Q2 2021 | $48,885,000 | +47.7% | 2,593,386 | +19.7% | 0.00% | 0.0% |
| Q1 2021 | $33,105,000 | +11.0% | 2,166,508 | +2.5% | 0.00% | 0.0% |
| Q4 2020 | $29,816,000 | +5.8% | 2,113,195 | +17.5% | 0.00% | 0.0% |
| Q3 2020 | $28,186,000 | -9.0% | 1,798,698 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $30,973,000 | +191.7% | 1,767,869 | +144.8% | 0.00% | 0.0% |
| Q1 2020 | $10,617,000 | -42.2% | 722,303 | -1.3% | 0.00% | 0.0% |
| Q4 2019 | $18,367,000 | +26.7% | 732,055 | -24.1% | 0.00% | 0.0% |
| Q3 2019 | $14,498,000 | -37.8% | 964,002 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $23,312,000 | +31.6% | 932,424 | +19.9% | 0.00% | 0.0% |
| Q1 2019 | $17,708,000 | -14.8% | 777,974 | +12.2% | 0.00% | 0.0% |
| Q4 2018 | $20,789,000 | +73.1% | 693,172 | +65.3% | 0.00% | 0.0% |
| Q3 2018 | $12,013,000 | – | 419,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |